Translational Lung Cancer Research

期刊名
Translational Lung Cancer Research

TRANSL LUNG CANCER R

ISSN / eISSN
2226-4477 / 2218-6751
目标和范围
Translational Lung Cancer Research(TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.
研究方向

肿瘤学

呼吸系统

CiteScore
7.20 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Oncology Q1 #92/404
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2024) 分区
ONCOLOGY Q2
RESPIRATORY SYSTEM Q1
出版国家或地区
Hong Kong
出版商
Society for Translational Medicine (STM)
出版周期
monthly
出版年份
2012
年文章数
172
Open Access
YES
通讯方式
Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started